Analysts expect Intel to report $13.15 billion in quarterly revenue, lower than the $13.28 billion it reported last year, ...
Intel surged 109% on U.S., Nvidia, and SoftBank investments. With Q3 earnings due, can weak fundamentals justify the rally—or ...
Intel stock is up over 80% year-to-date in 2025 helped by stakes in the company by Nvidia and the U.S. government.
Still, analysts are cautious heading into the report. They expect earnings of less than a penny per share on revenue of ...
Intel ($INTC) is set to report its Q3 earnings on Thursday, October 23, and the options market is hinting at a potentially ...
Legacy chipmaker Intel ($INTC) was the undisputed king of semiconductors, dominating global chip design and manufacturing for ...
NextSilicon, an Israeli startup, announced that it is developing a central processor aimed at challenging Intel Corp. (NASDAQ ...
Susquehanna has increased its price targets on an array of semiconductor stocks ahead of third-quarter financial results, ...
A notable Tesla Inc (NASDAQ:TSLA) bearish analyst shares thoughts on what the company will report for third-quarter financial ...
Based on the strong quarterly performance, Allegion raised its full-year 2025 revenue growth outlook to 7.0% to 8.0% on a reported basis, while maintaining its organic growth forecast of 3.5% to 4.5%.
Pinnacle West Capital will release its third-quarter earnings next month, and analysts anticipate a double-digit profit dip.
Following the strong results, West Pharmaceutical raised its full-year 2025 revenue guidance to $3.06-3.07 billion from $3.04-3.06 billion previously. The company also significantly increased its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results